Paris-based femtech company Sonio has received FDA 510(k) Regulatory Class II clearance for its product, Sonio Detect. Sonio’s technology aims to revolutionize the landscape of prenatal ultrasounds by offering an easy to use, manufacturer agnostic tool. Compatible with ultrasound devices from major manufacturers such as GE, Samsung, and Canon, Sonio Detect enables obstetricians, maternal-fetal medicine specialists, and sonographers to improve the quality…
Israeli pregnancy care company, Nuvo Group, announced on Friday its decision to merge with LAMF Global Ventures Corp. I (LGVC), a publicly traded special purpose acquisition company (SPAC). The strategic move aims to take Nuvo public. The impending transaction, which has secured unanimous approval from the boards of both companies, places Nuvo’s pre-money equity valuation at $269 million. This could potentially surge…
Sexual wellness brand HANX has unveiled two new natural supplements – Menopause Support and Pregnancy Support. These offerings, developed in-house by HANX Co-Founder Dr. Sarah Welsh, a former NHS gynaecology and obstetrics doctor, promise to provide much-needed assistance to women during crucial life stages. HANX’s latest supplements follow the success of its initial offering, Libido Lift, which experienced rapid demand and a…
The U.S. Food and Drug Administration (FDA) has approved Zurzuvae (zuranolone), the first oral medication indicated to treat postpartum depression (PPD) in adults. PPD is a major depressive episode that typically occurs after childbirth but can also begin during the later stages of pregnancy. Until now, treatment for PPD was only available as an IV injection given by a healthcare provider in certain healthcare…
Mirvie, a prenatal diagnostics company has received a $4.6M grant from the Bill & Melinda Gates Foundation to support the company’s efforts to predict unexpected pregnancy complications before they happen by revealing the underlying biology of each pregnancy for women on a global scale. Specifically, the funding will help launch study sites in Cameroon, Ghana, and Zambia to understand preeclampsia among pregnant…
The SKYLARK Study, conducted by The Feinstein Institutes for Medical Research at Northwell Health, has shown promising results in treating postpartum depression (PPD). Led by Dr. Kristina M. Deligiannidis, the trial evaluated the efficacy of an investigational oral neuroactive steroid, zuranolone (50mg). The findings suggest zuranolone could become the first oral, at-home therapy approved by the FDA for PPD. The study included…
Google has partnered with Soula, a Cyprus-based femtech startup, to enhance the support services available for pregnancy and parenting. This collaboration centers on Soula’s application of Google’s medical language model, Med-PaLM, to its AI-assistant. Med-PaLM is a highly sophisticated language model specifically designed to handle medical inquiries. By integrating this technology into its platform, Soula plans to offer comprehensive and reliable support…
Sonio, a French medtech company specializing in improving the health of pregnant individuals and children, has raised $14M in Series A funding led by Cross Border Impact Ventures and the Elaia funds. The funding follows the initial commitment of the EIC Fund (European Innovation Council) in December 2022 and will play a pivotal role in advancing Sonio’s SaaS solution, expanding its presence…
